Let's collaborate and create quality liposome encapsulated drugs together. Contact Us!
SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products.
Genetic platform
SyVento BioTech’s R&D Team offers technical and scientific support throughout the entire process, including advice on troubleshooting and optimization of RNA synthesis conditions. Our RNA synthesis proficiency guarantees successful results in downstream applications.
By incorporating these important features, our genetic platform for RNA synthesis
provides:
Delivery platform
Our Team’s qualifications and experience provide a wealth of expertise in the development of lipid-based delivery systems.
SyVento BioTech’s LNP delivery systems:
Manufacturing platform
Our capabilities offer the possibility of scaling the production of formulations based on lipid nanocarriers by transferring solutions developed in the laboratory on a semi-technical and technical scale.
Thanks to the extensive equipment base, we are able to perform:
Drug development expertise
August 1, 2025
SyVento BioTech Receives MIA Certification — First in Poland to Manufacture mRNA and LNP-Based Drug Products for Clinical TrialsSyVento BioTech is proud to announce that, as of 31 July 2025, the company has officially obtained the Manufacturer/Importer Authorisation (MIA) — a vital regulatory certification that enables the manufacturing and importation of sterile and biological investigational medicinal products in full compliance with Good Manufacturing Practice (GMP) standards. This certification marks a major milestone for […]
July 18, 2025
We are ready for BIO Asia-Taiwan 2025!We are proud to announce that SyVento BioTech will participate in BIO Asia–Taiwan 2025, one of the leading biotechnology and pharmaceutical events in the Asia-Pacific region. The exhibition and conference will take place from 23 to 27 July 2025 in Taipei. This international event brings together key innovators from across the life sciences sector. With […]
May 26, 2025
SyVento BioTech will be exhibiting at BIO International Convention 2025 in Boston!Join us from 16-19 June at Booth #949. As one of the world’s leading biotech events, BIO brings together thousands of innovators, investors, and industry leaders. For SyVento BioTech, it is a great opportunity to connect, collaborate, and showcase how our cutting-age solutions support development and delivery of next-generation mRNA therapeutics and other innovative medicines. […]
May 16, 2025
Let’s meet at TIDES USA!We are excited to announce that SyVento BioTech will be participating in 𝗧𝗜𝗗𝗘𝗦 𝗨𝗦𝗔, the leading event dedicated to oligonucleotide and peptide therapeutics. Representing us at the event will be Dylan Zuckerman – Business Development Manager, who will be available to connect, collaborate, and share insights into our latest advancements. Our services are designed to […]
May 13, 2025
We are shaping the future of next generation scientists!At SyVento BioTech, we are not just developing RNA-based therapies — we are helping shape the next generation of scientists who will revolutionize them! In collaboration with the Faculty of Biochemistry, Biophysics and Biotechnology at Jagiellonian University, we have co-created the course “RNA – from Biology to Biotechnology” for Biotechnology students.This program goes beyond lectures. […]
April 28, 2025
SyVento BioTech at BIO Korea 2025We are excited to announce that SyVento BioTech will be participating in BIO Korea 2025, one of Asia’s premier biotechnology and pharmaceutical events, taking place 7–9 May in Seoul. Our company will be proudly represented by Eliza Milewicz, Member of the Supervisory Board, who will be engaging in one-on-one partnering meetings, exploring collaborative opportunities, and […]
April 9, 2025
Let’s meet at World Vaccine Congress!We are excited to announce that SyVento BioTech will be attending the World Vaccine Congress in Washington, D.C. from April 22-24, 2025! This premier event brings together industry leaders to discuss groundbreaking advancements in vaccine development across infectious diseases, cancer immunotherapy, veterinary vaccines, and more. SyVento BioTech is committed to advancing vaccine technologies and biopharmaceutical […]
April 7, 2025
Join us at LNP Summit in Boston!SyVento BioTech is proud to announce our participation in the 4th LNP Formulation & Process Development Summit in Boston– the premier global forum dedicated exclusively to Lipid Nanoparticle (LNP) innovation! As a company at the forefront of advanced drug delivery technologies, we cannot miss the opportunity to attend this significant event. SyVento BioTech specializes in […]
April 1, 2025
SyVento BioTech at CDMO Live 2025!We are thrilled to share that SyVento BioTech will be a Silver Partner at CDMO Live this year. This is a fantastic event organized by Pharma Source that provides a unique platform to engage with industry expert, exchange insights, and present the innovative solutions shaping the future of science. We look forward to showcasing our […]
Let's collaborate and create quality liposome encapsulated drugs together.